database > company
Guided Therapeutics
Medical Devices & Tech
4955 Avalon Ridge Parkway
Norcross, GA 30071 USA
phone:770-242-8723
fax:770-242-8639
Symbol GHTP
Exchange
Founded
Employees
     www.guidedinc.com
Research Sector Medical Devices & Tech
Summary Description
Devoted to the painless detection of cervical disease.
Management
Mark L. Faupel, Ph.D., President, Chief Executive Officer and Director; Richard L. Fowler, Sr. Vice-president, Engineering; Shabbir Bambot, Ph.D. Vice President, Research and Development
Ownership
Financials


* numbers in thousands
 
Keywords
women's health, cervical, cervical cancer, hpv, screenings


Comment | Printable Version | Modify profile Feb. 01, 2010

Description
Guided Therapeutics, Inc. (Pink Sheets: GTHP) is developing a rapid and painless test for the early detection of disease that leads to cervical cancer. The technology is designed to quickly eliminate false positive Pap and HPV results and discover cervical disease missed by existing tests. Unlike Pap and HPV tests, the device does not require a painful tissue sample and results are known immediately. The Guided Therapeutics LightTouch™ device uses light to detect chemical and structural changes in cervical tissue. A broad array of light frequencies is shown on the cervix. Light that is returned from the cervix is analyzed by a spectrometer. Information from the spectrometer is then used to generate an image of the cervix showing healthy tissue from disease. This technology is called biophotonics. Biophotonics is the technology of using light and other energy to diagnose and monitor disease states. Light responds differently when exposed to normal cells and cancerous cells. Specifically the technology being developed for the cancer product is called hyperspectral imaging spectroscopy or HIS. HIS is capable of acquiring the individual spectrum of each cell component while it is in the body. The device then identifies physiological markers of cancer based on their spectral signatures.